Arşiv logosu
  • Türkçe
  • English
  • Giriş
    Yeni kullanıcı mısınız? Kayıt için tıklayın. Şifrenizi mi unuttunuz?
Arşiv logosu
  • Koleksiyonlar
  • DSpace İçeriği
  • Analiz
  • Türkçe
  • English
  • Giriş
    Yeni kullanıcı mısınız? Kayıt için tıklayın. Şifrenizi mi unuttunuz?
  1. Ana Sayfa
  2. Yazara Göre Listele

Yazar "Ayar, Ayar" seçeneğine göre listele

Listeleniyor 1 - 1 / 1
Sayfa Başına Sonuç
Sıralama seçenekleri
  • Yükleniyor...
    Küçük Resim
    Öğe
    Erythromycin Inhibits Prostaglandin F2?-İnduced Contractions of Myometrium Isolated From Non-Pregnant Rats
    (2002) Çelik, Hüsnü; Ayar, Ayar; Baltacı, Abdülkerim; Tuğ, Niyazi
    Objective: The aim of this study was to investigate the effects of erythromycin on prostaglandin F2? (PGF2?)-induced contractions of isolated myometrial strips from non-pregnant rats. Design: In vitro pharmacological study. Setting: Firat University Faculty of Medicine. Sample: Myometrium samples were taken from 55 adult Wistar rats. Methods: Myometrial strips were isolated from mature, non-pregnant Wistar rats. Isometric contractions of these strips were induced with 1 ?M PGF2?. Effects of 0.01, 0.1, 0.2, 0.5 and 1 mM erythromycin on the frequency and amplitude of these PGF2?-induced contractions were recorded. Main outcome measures: The inhibition of prostaglandin F2?-induced contractions in vitro. Results: Application of 0.01 mM erythromycin had no effect on either amplitude or frequency of contractions. However, 0.1, 0.2, 0.5 and 1 mM erythromycin decreased the frequency and amplitude of PGF2?-induced contractions. The inhibitory effect of erythromycin on amplitude was 27%, 38%, 54% and 83% (P < 0.05), and that on frequency was 10%, 16%, 32% and 61% (P < 0.05) at 0.1, 0.2, 0.5 and 1 mM concentrations, respectively. Conclusion: The results of this study demonstrate that erythromycin inhibits PGF2?-induced contractions in rat myometrium. Because PGF2?-induced contractions have been suggested to be involved in the pathogenesis of primary dysmenorrhoea, effects of erythromycin in this clinical entity may present a new approach for the treatment.

| Selçuk Üniversitesi | Kütüphane | Açık Erişim Politikası | Rehber | OAI-PMH |

Bu site Creative Commons Alıntı-Gayri Ticari-Türetilemez 4.0 Uluslararası Lisansı ile korunmaktadır.


Selçuk Üniversitesi Kütüphane ve Dokümantasyon Daire Başkanlığı, Konya, TÜRKİYE
İçerikte herhangi bir hata görürseniz lütfen bize bildirin

DSpace 7.6.1, Powered by İdeal DSpace

DSpace yazılımı telif hakkı © 2002-2025 LYRASIS

  • Çerez Ayarları
  • Gizlilik Politikası
  • Son Kullanıcı Sözleşmesi
  • Geri Bildirim